Yiheng Capital
Latest statistics and disclosures from Yiheng Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALAB, JD, NOAH, BILI, EDU, and represent 77.74% of Yiheng Capital Management's stock portfolio.
- Added to shares of these 5 stocks: ALAB (+$280M), RARE (+$6.8M), PONY, CLBT, GBIO.
- Started 5 new stock positions in CLBT, ALAB, PONY, GBIO, RARE.
- Reduced shares in these 10 stocks: JD (-$503M), BILI (-$257M), ULS (-$61M), PLNT (-$29M), VSAT (-$22M), AKRO (-$5.2M), EDU, HTHT, Generation Bio, NOAH.
- Sold out of its positions in Generation Bio, PLNT, ULS.
- Yiheng Capital Management was a net seller of stock by $-587M.
- Yiheng Capital Management has $678M in assets under management (AUM), dropping by -38.94%.
- Central Index Key (CIK): 0001447228
Tip: Access up to 7 years of quarterly data
Positions held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Yiheng Capital Management
Yiheng Capital Management holds 25 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Astera Labs Put Option (ALAB) | 41.2 | $280M | NEW | 1.4M | 195.80 |
|
| Jd.com Spon Ads Cl A (JD) | 13.4 | $91M | -84% | 2.6M | 34.98 |
|
| Noah Hldgs Spon Ads (NOAH) | 11.5 | $78M | 6.7M | 11.59 |
|
|
| Bilibili Spons Ads Rep Z (BILI) | 7.5 | $51M | -83% | 1.8M | 28.09 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 4.1 | $28M | -12% | 522k | 53.07 |
|
| ViaSat Put Option (VSAT) | 3.2 | $22M | -50% | 736k | 29.30 |
|
| H World Group Sponsored Ads (HTHT) | 2.6 | $18M | -6% | 457k | 39.11 |
|
| Inventiva Sa Ads (IVA) | 2.3 | $15M | 2.6M | 5.79 |
|
|
| Atre Sponsored Ads (RERE) | 2.1 | $15M | 3.2M | 4.60 |
|
|
| Acm Resh Com Cl A (ACMR) | 1.6 | $11M | 280k | 39.13 |
|
|
| Miragen Therapeutics (VRDN) | 1.6 | $11M | 500k | 21.58 |
|
|
| Akero Therapeutics (AKRO) | 1.3 | $9.1M | -36% | 191k | 47.48 |
|
| Kymera Therapeutics (KYMR) | 1.0 | $6.9M | 123k | 56.60 |
|
|
| Denali Therapeutics (DNLI) | 1.0 | $6.8M | 470k | 14.52 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 1.0 | $6.8M | NEW | 226k | 30.08 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 1.0 | $6.6M | 656k | 10.00 |
|
|
| Silvaco Group (SVCO) | 0.9 | $5.9M | 1.1M | 5.41 |
|
|
| Pony Ai Sponsored Ads (PONY) | 0.7 | $4.5M | NEW | 200k | 22.49 |
|
| Cellebrite Di Ordinary Shares (CLBT) | 0.6 | $4.3M | NEW | 231k | 18.53 |
|
| Tal Education Group Sponsored Ads (TAL) | 0.5 | $3.5M | 309k | 11.20 |
|
|
| Agora Ads (API) | 0.3 | $2.0M | 534k | 3.82 |
|
|
| Beam Therapeutics (BEAM) | 0.2 | $1.7M | 69k | 24.27 |
|
|
| Yatsen Hldg Sponsored Ads (YSG) | 0.1 | $873k | 96k | 9.06 |
|
|
| Generation Bio Com New (GBIO) | 0.1 | $646k | NEW | 106k | 6.12 |
|
| Tuniu Corp Sponsored Ads (TOUR) | 0.0 | $299k | 314k | 0.95 |
|
Past Filings by Yiheng Capital Management
SEC 13F filings are viewable for Yiheng Capital Management going back to 2015
- Yiheng Capital Management 2025 Q3 filed Nov. 14, 2025
- Yiheng Capital Management 2025 Q2 filed Aug. 14, 2025
- Yiheng Capital Management 2025 Q1 restated filed May 16, 2025
- Yiheng Capital Management 2024 Q4 filed Feb. 11, 2025
- Yiheng Capital Management 2024 Q3 filed Nov. 12, 2024
- Yiheng Capital Management 2024 Q2 filed Aug. 14, 2024
- Yiheng Capital Management 2024 Q1 filed May 15, 2024
- Yiheng Capital Management 2023 Q4 filed Feb. 14, 2024
- Yiheng Capital Management 2023 Q3 filed Nov. 14, 2023
- Yiheng Capital Management 2023 Q2 filed Aug. 14, 2023
- Yiheng Capital Management 2023 Q1 filed May 15, 2023
- Yiheng Capital Management 2022 Q4 filed Feb. 14, 2023
- Yiheng Capital Management 2022 Q3 filed Nov. 14, 2022
- Yiheng Capital Management 2022 Q2 filed Aug. 15, 2022
- Yiheng Capital Management 2022 Q1 filed May 16, 2022
- Yiheng Capital Management 2021 Q4 filed Feb. 14, 2022